Email Updates

You are here

Home

AVAC's Blog: P-Values

  • Discussion with Jon Cohen on HIV and COVID-19 Vaccine Research

    Six months? A year? Longer? Never? How long until there’s a vaccine against COVID-19? How is COVID vaccine research moving so quickly? How do HIV vaccine and COVID-19 vaccine research relate and inform each other? Jon Cohen, one of the leading journalists covering both HIV and COVID recently joined us for a webinar.

    May 7, 2020
    HIV Vaccine
    AVAC

  • AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies

    The WHO Working Group has articulated important criteria for assessing a challenge study, but we believe that they left out the most important one: Until there is an approved treatment, a challenge trial with a potentially fatal and as-yet untreatable pathogen is unacceptable.

    May 7, 2020
    AVAC
    Treatment Action Group

  • Critical Resources for Today’s Advocacy

    To make headway against both HIV and COVID-19, we must demand commitment to science and evidence, collaboration and innovation. And we must work together with undaunted commitment.

    May 5, 2020
    General
    AVAC

  • The Integration of HIV & SRH: Tools and more to advance the work

    For women all over the world, getting the products and services they need and want for HIV prevention and for sexual & reproductive health (SRH) are mired in challenges – and COVID-19 is intensifying the struggle. Siloed care, stock outs, and too little input from women themselves on the design of programs and products are among the long-standing barriers to women’s healthcare, and COVID-19 exacerbates these difficulties. AVAC is expanding our partnerships and programs to meet these challenges.

    April 30, 2020
    AVAC

  • May 7 Webinar: The power—and pitfalls—of modeling for COVID-19 and HIV

    New COVID-19 mathematical models are emerging to predict trends in new infections and deaths in cities, countries and globally. These models can forecast medical supply shortages, and influence policy makers and investment of resources. Strengthening our understanding of current models, how they are developed, and their limitations, allows us to better apply modeling to public health policies and programs.

    April 28, 2020
    AVAC

  • New Resources to Track the Impact of COVID-19 on HIV Prevention Research

    In the midst of the global response to COVID-19, everyone and everything is affected, and HIV prevention research is no exception.

    April 21, 2020
    AVAC

  • HIV Advocacy Community Calls for Ethical Research for COVID-19 Solutions

    More than 260 organizations and individuals have joined an Advocates Call for Ethical Research for COVID-19 Solutions. Read the letter reiterating the essential role of ethical research, and the need to move forward based on facts and evidence, and help us carry this message forward!

    April 20, 2020
    AVAC

  • Advocates Condemn Cuts to WHO

    AVAC, Health GAP, Knowledge Ecology International (KEI) and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.
    April 16, 2020
    AVAC
    Health GAP
    Knowledge Ecology International
    Treatment Action Group

  • New Resources on AVAC.org and PrEPWatch.org

    On the heels of our spotlight last week looking at the intersection of COVID-19 and HIV, this edition of the Advocates Network features new resources for HIV prevention research and advocacy, work that’s as important today as ever before. Both HIV and COVID-19 are urgent matters of public health, demanding a sustained commitment. Use these tools to stay informed and connected, and scroll down for COVID-19 materials.

    April 15, 2020
    HIV Vaccine, PrEP
    AVAC

  • Programs, Products, Services and Users: HIV & SRH integration is the future of prevention

    Integrating HIV and SRH has been successfully put into practice for family planning in HIV care and treatment clinics and prevention of mother-to-child transmission services in maternal and child health clinics. But integrating HIV prevention—most recently the addition of oral PrEP—and SRH services has been slow.

    April 14, 2020
    AVAC

Pages

view more